|
|
|
|
LEADER |
03342nam a2200529 4500 |
001 |
ocn973396828 |
003 |
OCoLC |
005 |
20180501122035.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
170222s2017 maua o 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d IDEBK
|d EBLCP
|d N$T
|d YDX
|d OCLCF
|d OCLCQ
|d MEU
|d GrThAP
|
066 |
|
|
|c (S
|
019 |
|
|
|a 973506691
|a 973755068
|a 973798715
|a 973907039
|a 974033102
|a 1028922417
|a 1030785129
|
020 |
|
|
|a 9780128123911
|q (electronic bk.)
|
020 |
|
|
|a 0128123915
|q (electronic bk.)
|
020 |
|
|
|a 9780128123904
|q (print)
|
020 |
|
|
|a 0128123907
|
035 |
|
|
|a (OCoLC)973396828
|z (OCoLC)973506691
|z (OCoLC)973755068
|z (OCoLC)973798715
|z (OCoLC)973907039
|z (OCoLC)974033102
|z (OCoLC)1028922417
|z (OCoLC)1030785129
|
050 |
|
4 |
|a QH599
|b .C47 2017eb
|
072 |
|
7 |
|a SCI
|x 007000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|2 ukslc
|
082 |
0 |
4 |
|a 572.8/7
|2 23
|
049 |
|
|
|a TEFA
|
245 |
0 |
0 |
|a Chromatin Proteins and Transcription Factors as Therapeutic Targets /
|c edited by Rossen Donev.
|
264 |
|
1 |
|a Cambridge, MA :
|b Academic Press is an imprint of Elsevier,
|c 2017.
|
300 |
|
|
|a 1 online resource (xvi, 369 pages :
|b color illustrations).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in protein chemistry and structural biology ;
|v volume 107
|
546 |
|
|
|a Text in English.
|
500 |
|
|
|a Includes indexes.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed February 24, 2017).
|
505 |
8 |
|
|a 2.2.1. Posttranslational Acetylation2.2.2. Oxidation; 2.3. HMGB1-Receptor Families; 2.3.1. Receptor for Advanced Glycation End Products; 2.3.2. Toll-Like Receptors; 2.3.3. Recently Discovered HMGB1 Receptors; 3. HMGB1 in the Nucleus-An Architectural Factor; 3.1. Nucleolar Functions; 3.1.1. DNA Replication, Repair, and V(D)J Recombination; 3.1.2. Gene Transcription Transfer and Delivery; 3.1.3. Nucleosome Structure and Dynamics; 3.1.4. Telomere Homeostasis; 3.2. HMGB1 as a Damage Recognition Protein Mediating the Antitumor Effect of the Chemotherapeutic Drug cis-Platin
|
505 |
8 |
|
|a 3.3. HMGB1 Protein-An Important Player in cis-platin-Based Therapy3.3.1. HMGB1 Affects the Repair of DNA Damaged by the Antitumor Drug cis-Platin In Vitro; 3.3.2. The Impact of HMGB1 Protein for the Repair Potential of Human Cancer Cell Lines: A Significant Issue for Therapeut ...; 4. HMGB1 Outside the Cell; 4.1. HMGB1 as a Signaling Molecule; 4.2. HMGB1 and Diseases; 5. HMGB1 as a Therapeutic Target; 5.1. Antibody-Based Targeting; 5.2. Peptides and Protein Inhibitors of HMGB1; 5.3. Blockage of HMGB1-Receptor Signaling; 5.4. Small Molecules Inhibiting HMGB1
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
650 |
|
0 |
|a Chromatin.
|
650 |
|
0 |
|a Transcription factors.
|
650 |
|
7 |
|a SCIENCE / Life Sciences / Biochemistry
|2 bisacsh
|
650 |
|
7 |
|a Chromatin.
|2 fast
|0 (OCoLC)fst00859922
|
650 |
|
7 |
|a Transcription factors.
|2 fast
|0 (OCoLC)fst01154564
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Donev, Rossen,
|e editor.
|
776 |
0 |
8 |
|c Original
|z 0128123907
|z 9780128123904
|w (OCoLC)959869209
|
830 |
|
0 |
|a Advances in protein chemistry and structural biology ;
|v v. 107.
|
856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/18761623/107
|z Full Text via HEAL-Link
|